当前位置:主页 > 医学论文 > 泌尿论文 >

低能量冲击波和骨髓间充质干细胞对慢性环孢素肾病大鼠的治疗研究

发布时间:2018-06-30 20:24

  本文选题:低能量冲击波 + 骨髓间充质干细胞 ; 参考:《第二军医大学》2017年博士论文


【摘要】:背景:冲击波属于机械波,做为无创物理治疗方法已经应用临床30余年。从最初的体外碎石治疗,再发展到骨不连、疼痛治疗,特别是在上世纪发现低能量冲击波对于慢性缺血性疾病的改善治疗作用,使得冲击波的应用范围越来越广阔。慢性肾脏疾病是我国的常见病多发病,我国约有1.2亿慢性肾脏疾病患者,然而对于绝大多数的肾脏疾病,特别是慢性肾功能不全目前还缺乏有效的治疗手段。肾脏局部微循环障碍、小管间质纤维化在慢性肾脏疾病发生发展中起至关重要的作用。低能量冲击波治疗作为一种新型治疗手段是否也能对慢性肾功能不全有效目前尚未有报道。干细胞治疗技术是目前医学研究的热点,近年来关于干细胞治疗慢性肾脏疾病基础及临床研究有大量报道,干细胞治疗业已被证实在急性肾损伤、肾小管损伤修复、缺血性肾脏病、肾间质纤维化防治方面有一定疗效。在体外实验中低能量冲击波曾有报道可以增强干细胞的分化和迁徙能力,那么在体内是否也能增强干细胞治疗的作用,目前尚未有相关文献报道。为了证实以上的假说,我们选取慢性环孢霉素肾病模型作为治疗对象,环孢霉素是肾脏病领域治疗的常见药物,主要用于肾移植排斥、肾病综合征、自身免疫系统疾病等的治疗,但其副作用是可能引起慢性环孢素肾病,其主要病理特征有入球小动脉透明样变性、灶状和条带状肾间质纤维化、肾小管萎缩、炎性细胞浸润。缺血性损害是其肾毒性的主要机制,而这也正是低能量冲击波和骨髓间充质干细胞治疗的长处所在。为此在本研究中我们选取环孢素肾病模型,使用低能量冲击波和骨髓间充质干细胞进行干预,观察低能量冲击波、干细胞技术是否对慢性肾脏病有治疗效果,同时观察低能量冲击波、干细胞技术间是否有协同作用,探索低能量冲击波应用于慢性肾脏病治疗的可行性以及其与干细胞共同应用的前景。研究目的:观察低能量冲击波、干细胞治疗技术是否对慢性环孢素肾病具有治疗作用,两者间能否有协同作用,并初步探讨其机制。研究方法:1.使用不同能量级(6、8、10、12KV)的冲击波干预正常SD大鼠,动态监测肾脏功能(血肌酐、尿素氮)及大鼠生长情况变化,28d切取肾脏进行组织形态学评估,同时测定部分细胞因子的表达水平,为下一步实验选取合适的冲击波能量级。2.实验大鼠分成5组:c组:正常对照组;h组:模型组;l1、l2、l5组:8KV冲击波干预组,分别于第7、14,21天给予冲击波治疗,l1组(每次左右肾各100次)、l2组(每次左右肾各冲击200次)、l5组(每次左右肾各冲击500次);,动态监测肾脏功能(血肌酐、血尿素氮)及大鼠生长情况变化,28d切取肾脏进行组织形态学评估,同时测定部分细胞因子(α-SMA、TGF-β_1、NF-κB、VEGF)的表达水平。3.实验大鼠分成5组:c组:正常对照组;h组:模型组;l组:低能冲击波干预组;b组:干细胞治疗组;bl组:低能冲击波联合干细胞治疗组,动态监测肾脏功能(血肌酐、血尿素氮)及大鼠生长情况变化,28d切取肾脏进行组织形态学评估,同时测定部分细胞因子(α-SMA、TGF-β_1、NF-κB、VEGF)的表达水平。结果:1.与正常对照组比较,低能量冲击波治疗组(6KV、8KV)在肾组织形态上无明显改变,10KV组的肾脏组织中可见到少量的肾脏淤血情况,12KV干预组大鼠皮肤可见瘀斑,肾脏表面也可见到有散在的出血点,肾组织内有较多的肾脏淤血情况,肾小管可以见到浊肿发生。肾功能和体重情况,与正常对照组比较,不同能量级冲击波干预组的血肌酐、血尿素氮、体重变化趋势无明显差别,差异不具有统计学意义。肾间质纤维化(RIF)评分,与正常对照组比较,低能量冲击波治疗组(6KV、8KV)肾间质纤维化评分无明显差别,10KV和12KV的RIF评分较正常组升高,差异具有显著性。2.与c组比较,h组与冲击波治疗组(l1、l2、l5组)在体重、血肌酐、血尿素氮水平均显著升高,差异具有统计学意义。与h组相对比,l1、l2组血肌酐、血尿素氮水平有明显下降,体重增加。但是l5血肌酐、尿素氮、体重水平与h组大鼠无显著差异。肾组织形态上,模型组与治疗组都出现了明显的肾脏损害,RIF评分均显著升高。与h组比较,l1、l2组RIF评分显著下降,但是l5组与h组之间比较RIF评分高于模型组,差异有统计学意义。在机制初步探索上,与肾脏病进展密切相关的因子α-SMA、TGF-β1、NF-κB、VEGF在模型组和干预组之中表达均明显上升。与H组比较,L1、L2组的上述因子表达程度有所下降,而L5组大鼠的肾脏上述因子表达水平比模型组大鼠显著升高,差异有统计学意义。3.与C组比较,H组与治疗组(L、B、BL组)的血肌酐、尿素氮水平均显著升高,体重显著下降。与H组比较,L、B、BL组对大鼠的血肌酐、尿素氮水平有明显下降,体重增加。肾组织形态上,模型组与治疗组都出现了明显的肾脏损害,RIF评分均显著升高;与H组比较,L、B、BL组RIF评分显著下降。细胞因子表达上α-SMA、TGF-β1、NF-κB、VEGF在模型组和治疗组之中均明显上升。但是BL组与B组比较,在血肌酐、尿素氮水平、体重、RIF评分、细胞因子表达水平上均无显著差异。结论:适量的低能量冲击波治疗和骨髓间充质干细胞治疗对慢性环孢素肾病大鼠有改善作用,两者间在体内未发现协同作用,两者改善肾功能的机理仍需进一步的研究。
[Abstract]:Background: shock wave is a mechanical wave. It has been used as a noninvasive physical therapy for more than 30 years. From the original extracorporeal lithotripsy treatment to bone nonunion and pain treatment, especially in the last century, it was found that low energy shock waves were used to improve the treatment of chronic ischemic diseases, which made the application of shock waves wider and wider. There are about 120 million chronic renal diseases in our country. There are about 120 million patients with chronic kidney disease in our country. However, most renal diseases, especially chronic renal insufficiency, are still lack of effective treatment. The local microcirculation disorder of the kidney and tubulointerstitial fibrosis are important in the development of chronic renal disease. Low energy shock wave therapy is not yet reported as a new therapy for chronic renal insufficiency. Stem cell therapy is a hot spot in medical research. In recent years, the basic and clinical research of stem cell therapy for chronic kidney disease has been reported. Stem cell therapy has been proved to be urgent. There is a certain effect on renal injury, renal tubular injury repair, ischemic kidney disease, and renal interstitial fibrosis. In vitro, low energy shock waves have been reported to enhance the differentiation and migration of stem cells, and whether the role of stem cell therapy can be enhanced in the body. The above hypothesis, we choose chronic cyclosporin nephropathy model as an object of treatment, cyclosporin is a common drug in the field of kidney disease, mainly used in the treatment of renal transplant rejection, nephrotic syndrome, and autoimmune disease, but its side effect is the possible cause of slow cyclosporin nephropathy, its main pathological feature is a small ball movement. Hyaline degeneration, focal and banded renal interstitial fibrosis, renal tubules atrophy, and inflammatory cell infiltration. Ischemic damage is the main mechanism of its renal toxicity, and this is the advantage of the low energy shock wave and bone marrow mesenchymal stem cells. In this study we selected cyclosporine nephropathy model and use low energy shock wave. Intervention with bone marrow mesenchymal stem cells to observe the effects of low energy shock wave, stem cell technology on chronic kidney disease, and whether there is a synergistic effect between low energy shock wave and stem cell technology, explore the feasibility of low energy shock wave for chronic kidney disease and the prospect of CO application with stem cells. The purpose of this study is to observe the therapeutic effect of low energy shock wave and stem cell therapy on chronic cyclosporin nephropathy, whether there is a synergistic effect between them and explore its mechanism. 1. the methods of study: 1. the normal SD rats were interfered with different energy levels (6,8,10,12KV), and the dynamic monitoring of renal function (blood creatinine, urea nitrogen) and large amount of renal function (blood creatinine, urea nitrogen) The rat growth was changed. 28d was cut into the kidney for histomorphological evaluation, and the expression level of some cytokines was measured. The next experiment was divided into 5 groups: the C group: the normal control group, the H group, the model group, the L1, L2, L5 group: the 8KV shock wave intervention group, which were given the impact wave treatment at day 7,14,21, respectively. Treatment, group L1 (100 times of kidney each time), group L2 (200 times of renal impact each time), group L5 (500 times each kidney), and the dynamic monitoring of renal function (blood creatinine, blood urea nitrogen) and rats' growth changes. 28d was taken for histomorphological evaluation of kidney, and a table of some cytokines (alpha -SMA, TGF- beta _1, NF- kappa B, VEGF) was measured. .3. rats were divided into 5 groups: Group C: normal control group; group H: model group; group L: low-energy shock wave intervention group; B group: stem cell therapy group; BL group: low-energy shock wave combined with stem cell therapy group, dynamic monitoring of renal function (blood creatinine, blood urea nitrogen) and rat growth, 28d cut kidney for histomorphological assessment, simultaneous measurement of kidney, simultaneous measurement of kidney, simultaneous measurement and measurement of kidney, simultaneous measurement and measurement of kidney, simultaneous measurement of kidney The expression level of partial cytokine (alpha -SMA, TGF- beta _1, NF- kappa B, VEGF). Results: 1. compared with the normal control group, there was no significant change in the renal tissue morphology of the low energy shock wave group (6KV, 8KV), and a small amount of renal congestion in the renal tissue of the 10KV group. The skin of the 12KV intervention group was seen in the skin of the rats and the surface of the kidney was also visible. There were scattered bleeding points, more renal blood stasis in renal tissue, renal tubules can be seen cloudy swelling, renal function and body weight, compared with the normal control group, there was no significant difference in blood creatinine, blood urea nitrogen and body weight in different energy level shock wave intervention group, and the difference was not statistically significant. RIF evaluation was not significant. Compared with the normal control group, there was no significant difference in the renal interstitial fibrosis score of the low energy shock wave therapy group (6KV, 8KV). The RIF score of 10KV and 12KV was higher than that of the normal group. The difference was significant between the.2. and the C group. The difference was statistically significant between the H group and the shock wave group (L1, L2, L5 group) in the body weight, the blood creatinine and the blood urea nitrogen water. Significance. Compared with group H, L1, L2 group blood creatinine, blood urea nitrogen level obviously decreased, weight increased. But L5 blood creatinine, urea nitrogen, body weight level had no significant difference with the H group. The renal tissue morphology, both the model group and the treatment group had obvious renal damage, and the RIF score increased significantly. Compared with the H group, the RIF score of L1 and L2 group was significantly lower. But the RIF score of L5 group and H group was higher than that of the model group, and the difference was statistically significant. In the preliminary exploration of the mechanism, the expression of factor alpha -SMA, TGF- beta 1, NF- kappa B, VEGF in the model group and the intervention group were obviously increased. Compared with the H group, the expression degree of the above-mentioned factors in L1 and L2 group decreased, while L5 group was larger. The expression level of the above factors in the rat kidney was significantly higher than that in the model group. The difference was statistically significant between the.3. and the C group. The blood creatinine in the H group and the treatment group (L, B, BL group) increased significantly and the body weight decreased significantly. Compared with the H group, the serum creatinine and the urea nitrogen level of the rats were significantly decreased, and the body weight was increased. The body weight was increased. The renal tissue shape was increased. In the model group, both the model group and the treatment group had obvious renal damage, and the RIF score increased significantly. Compared with the H group, the RIF scores in the L, B and BL groups decreased significantly. The expression of alpha, TGF- beta 1, NF- kappa B, VEGF in the model group and the treatment group were significantly higher than that in the H group. There is no significant difference in the expression level of cytokine. Conclusion: a moderate amount of low energy shock wave therapy and bone marrow mesenchymal stem cell therapy can improve the chronic cyclosporin nephropathy, and there is no synergistic effect between the two. The mechanism of improving renal function still needs further study.
【学位授予单位】:第二军医大学
【学位级别】:博士
【学位授予年份】:2017
【分类号】:R692

【相似文献】

相关期刊论文 前10条

1 佘妙容,黄梓伦;比较单用环孢素与联用抗胸腺细胞球蛋白和环孢素治疗非重型再生障碍性贫血病人的前瞻性随机多中心研究[J];国外医学(内科学分册);2000年04期

2 赵亮,王文建,李磊;环孢素A治疗难治性特发性血小板减少性紫癜14例观察[J];青海医药杂志;2000年05期

3 郭长升 ,孙玉霞,唐家宏 ,宋宗昌 ,朱璐;联合环孢素治疗难治性血小板减少性紫癜22例[J];人民军医;2003年12期

4 尤成升;脾照射加口服环孢素治疗血小板减少性紫癜[J];临床军医杂志;2004年04期

5 杨兆军;环孢素A联合肌甘、辅酶A治疗特发性血小板减少性紫癜7例分析[J];医学信息;2005年07期

6 柳建发,蒋雯雯;环孢素的生物性研究[J];地方病通报;2005年04期

7 Odaka M.;Tatsumoto M.;Susuki K. ;史焕昌;;环孢素成功治疗顽固性慢性炎症性脱髓鞘性多发性神经病[J];世界核心医学期刊文摘(神经病学分册);2005年11期

8 闫林英;王兴旺;;环孢素A治疗难治性血小板减少性紫癜15例疗效观察[J];中医临床研究;2011年21期

9 HandJP,寇伟,文映碧;用环孢素A成功治疗难治性血栓性血小板减少性紫癜[J];国外医学(内科学分册);1999年09期

10 MurthyMVR,廖福荣;21-8 用Tolypocladium inflatum固态发酵生产环孢素[J];国外医药(抗生素分册);2000年01期

相关会议论文 前10条

1 徐忠金;梁昌达;曾毓华;邹发东;;环孢素A治疗小儿重型再生障碍性贫血疗效观察[A];2005年华东六省一市血液病学学术会议暨浙江省血液病学学术年会论文汇编[C];2005年

2 康登保;赵雅静;康建华;刘天斌;;免疫性血小板减少性紫癜应用环孢素A治疗的疗效分析[A];2005年华东六省一市血液病学学术会议暨浙江省血液病学学术年会论文汇编[C];2005年

3 古丽苏木;石雨薇;阿迪娜;马依拉;;环孢素A治疗难治性特发性血小板减少性紫癜9例报告[A];中华医学会血液学分会第十三届全国血栓与止血学术会议暨“血栓栓塞性疾病(血栓与止血)基础与临床研究进展”论文摘要汇编及学习班讲义[C];2011年

4 尚明花;张树俭;范昱;姚建;徐琴君;;肾素-血管紧张素系统在慢性环孢素肾病中作用的研究[A];2007年浙沪两地肾脏病学术年会资料汇编[C];2007年

5 王培培;栾家杰;;1例异基因外周血造血干细胞移植患者术后应用环孢素的药学监护[A];安徽省药理学会2012年学术年会论文汇编[C];2012年

6 黄黎;匡跃敏;蒋志勇;;环孢素A治疗难治性特发性血小板减少性紫癜的临床观察[A];2009年浙江省血液病学学术年会论文集[C];2009年

7 江灏;;环孢素A的临床应用及研究进展[A];2013年中国临床药学学术年会暨第九届临床药师论坛论文集[C];2013年

8 张俊鹏;李瑞明;林颖;王振宁;;环孢素A植入微球的制备[A];共铸医药学术新文明——2012年广东省药师周大会论文集[C];2012年

9 魏宗有;王娟;陈宇翔;陈忠;;环孢素眼用乳剂的制备及初步质量评估[A];第十二届全国抗生素学术会议论文集[C];2013年

10 郭亚乐;黄绍平;李丹;赵小鸽;杨琳;周戬平;王雪莹;;环孢素A抑制未成熟脑多要耐药基因的剂量探讨[A];中华医学会第十五次全国儿科学术大会论文汇编(上册)[C];2010年

相关重要报纸文章 前10条

1 赵瑞祥;环孢素临床应用新进展[N];中国医药报;2001年

2 赵瑞祥;环孢素临床应用新发现[N];中国医药报;2002年

3 刘文山;环孢素A治疗非血液病[N];中国医药报;2000年

4 冯友根;黄连素联用环孢素A增效[N];中国医药报;2004年

5 国讯;国家局提醒 转换使用不同环孢素制剂可能带来风险[N];中国医药报;2010年

6 本报记者 唐夏;赵志刚:切勿转换使用不同环孢素制剂[N];中国消费者报;2010年

7 卢敏政;环孢素传奇[N];科技日报;2000年

8 ;环孢素临床应用新发现[N];中国医药报;2002年

9 ;警惕不同商品名或制剂的环孢素替换使用的风险[N];中国医药报;2010年

10 驻京记者 金丰杰;华药环孢素年销售过亿元[N];医药经济报;2004年

相关博士学位论文 前7条

1 韩玮;难治性溃疡性结肠炎早期预测、临床转归及药物治疗的评价[D];安徽医科大学;2015年

2 张勇;低能量冲击波和骨髓间充质干细胞对慢性环孢素肾病大鼠的治疗研究[D];第二军医大学;2017年

3 曹良国;环孢素A动脉灌注局部免疫抑制在大鼠异体后肢移植中的应用[D];南方医科大学;2012年

4 魏春敏;CYP2E1酶在去甲斑蝥素代谢和环孢素诱导肝损伤中的作用研究[D];山东大学;2014年

5 李旭东;肾移植术后应用环孢素A有效性及安全性系列研究的系统评价[D];四川大学;2005年

6 蔡涛;IL-22在Behcet病及Vogt-小柳原田综合征中的表达及其影响因素的研究[D];重庆医科大学;2012年

7 程根阳;罗格列酮防治环孢素A所致大鼠肝肾毒性的分子机制研究[D];郑州大学;2010年

相关硕士学位论文 前10条

1 杨莉莉;小剂量环孢素A治疗非重型再生障碍性贫血的疗效与血药浓度关系的临床研究[D];泰山医学院;2014年

2 叶,

本文编号:2086741


资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/mjlw/2086741.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户edde7***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com